Mawi DNA is working with Biotessia to start a local production site for DNA sample collection technologies and kits. These will be provided to African markets at a significantly lower cost.
Mawi DNA Technologies (Mawi), a leading biosample collection company, is engaging in a joint venture with Moroccan medical device company BIOTESSIA to serve the African market.
The goal of Mawi DNA and Biotessia’s joint venture is to produce DNA/RNA, Forensics, Microbiome and blood room temperature stable bio-sample collection technologies and kits in Morocco, targeting African and European countries. Aiming to provide high quality DNA sampling at more affordable prices.
The two companies secured a grant from Morocco’s government for 25% of the capital required to start the project The funding will support Biotessia’s vision to distribute diagnostic tests that help detect common diseases in Morocco and Africa, especially in the rural and secluded areas of the continent.
iSWAB®-DNA Is in a League of Its Own Among Non-Invasive…...
Key Highlights:
Visit the Mawi DNA Team (Booth #1465) at ADLM 2024,…...
Every year the Association for Diagnostics & Laboratory Medicine (ADLM) (formerly AACC) gives laboratory medicine professionals the opportunity to connect with global leaders in clinical chemistry...
READ MOREVisit the Mawi DNA Team (Booth #B704) at PMWC 2024,…...
JOIN US AT PMWC | Jan. 24-26, 2024 | Silicon Valley | California READ MORE